Head-to-head · WeighScore
AgelessRx vs Roen Rx
By GLP-1 ScorecardUpdated
Score comparison
AgelessRx has the higher recorded score — 84.3/100 to 55.4/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | Roen Rx |
|---|---|---|
| WeighScore | 84.3/100 | 55.4/100 |
| Grade | B | C |
| Site position | #17 | #489 |
| Semaglutide | Not verified (current medication-specific quote required) | $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | $216/mo (3-month offer, plus a separate fee, compounded) |
| Coverage | Advertises US service; confirm treatment-specific state availability | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Not confirmed |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
Site position #489 · C
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
Strengths
- Insurance coordination for eligible branded prescriptions
- General membership and separate medication-included bundles
- Dedicated wellness coaching and secure messaging
- Quarterly compounded medication offers, with separate care fees to confirm
What to consider
- Confirm treatment-specific state eligibility and assigned clinician/pharmacy
- Insurance coverage and a $25 copay are not guaranteed
- General membership excludes medication; separate bundles include it with possible higher-dose extras
- Weight-loss coaches are not licensed dietitians or nutritionists
- Full ineligibility-refund advertising differs from general nonrefundable fees; confirm the selected exception
- FDA issued Roen Health, Inc. dba RoenRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.